| Serial Number | 79209728 |
| Word Mark | IMRELIX |
| Filing Date | Thursday, March 23, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, November 8, 2024 |
| Registration Number | 5450609 |
| Registration Date | Tuesday, April 24, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 6, 2018 |
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of viral and infectious diseases and pharmaceutical preparations for the treatment of immune dysfunction and pharmaceutical preparations for the treatment of human immunodeficiency virus |
| Goods and Services | Information and advice relating to pharmaceutical preparations, diseases and medical conditions and treatment, namely, information and advice on-line via computer networks or the Internet and providing information relating to prevention, diagnosis and treatment of infectious diseases and information and advice relating to diagnosis and treatment of diseases and medical disorders |
| Goods and Services | Scientific research within the medical, pharmaceutical and bacteriological area, namely, Synthetic chemistry and generation of new chemical entities based on molecular structures of macrolides and of GnRH molecules to identify specific lead drug candidates for infectious diseases. Toxicology studies and preparation of investigational new drugs (INDs) according to good laboratory practice (GLP) standard operating procedures, analysis of pharmacokinetics and metabolism of drugs and new chemical entities, preparation of pharmaceutical formulations, high-throughput screening of new chemical entities in the field of anti-viral therapeutics, and consultancy and information relating thereto, conducting of tests regarding medical applications; packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, design and development of granulation technology and tablet technology namely, selection of lead drug candidates in the field of anti-viral therapeutics based on specific molecular structures, design of pharmaceutical and medical preparations through analysis of pharmacokinetics and metbolism of drugs and new chemical entities, manufacturing of pharmaceutical formulations according to good manufacturing practice (GMP) standard operating procedures, and consultancy and information relating thereto |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, November 8, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, November 8, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, November 8, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ISR Immune System Regulation Holding AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
| Party Name | Immune System Regulation Holding AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
| Party Name | Immune System Regulation Holding AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
| Event Date | Event Description |
| Thursday, June 8, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, June 13, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 15, 2017 | ASSIGNED TO EXAMINER |
| Saturday, June 17, 2017 | APPLICATION FILING RECEIPT MAILED |
| Monday, June 19, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 20, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, June 29, 2017 | REFUSAL PROCESSED BY MPU |
| Thursday, June 29, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, July 14, 2017 | REFUSAL PROCESSED BY IB |
| Wednesday, December 13, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 20, 2017 | ASSIGNED TO LIE |
| Friday, December 22, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 22, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 28, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 17, 2018 | NOTICE OF PUBLICATION |
| Tuesday, February 6, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 24, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 24, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, August 6, 2018 | FINAL DISPOSITION PROCESSED |
| Monday, August 6, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 31, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, January 24, 2019 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Thursday, October 28, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, February 18, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, November 8, 2024 | CANCELLED SECTION 71 |